Drug Profile
Research programme: diabetes/obesity therapeutics - ChemGenex
Alternative Names: CXS-829Latest Information Update: 30 Oct 2008
Price :
$50
*
At a glance
- Originator ChemGenex Pharmaceuticals
- Class Small molecules
- Mechanism of Action Ion channel modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diabetes mellitus
Most Recent Events
- 30 Oct 2008 Discontinued - Preclinical for Diabetes mellitus in Australia (unspecified route)